U.S. time, ImmVira's brand new oncolytic herpes simplex virus ("oHSV") product MVR-C5252 targeting Malignant Glioma has obtained Orphan Drug Designation ("ODD") from U.S. Food...
Celyad Oncology SA, a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer,...
The Lenstec SBL-3 IOL (Segmented Bifocal Lens) is a next-generation asymmetric multifocal refractive IOL which provides patients with near, intermediate and distance vision. Its...
SHINE Technologies, LLC, a next-generation nuclear technology company, announced the company has submitted a Drug Master File (DMF) with the U.S. Food and Drug...
Artivion, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced that it has initiated enrollment in the PERSEVERE clinical trial...
